Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merck & Co.’s shares rise over 7% thanks to new positive clinical results from Keytruda
Merck & Co.’s shares rise over 7% thanks to new positive clinical results from Keytruda
Merck & Co.’s shares rise over 7% thanks to new positive clinical results from Keytruda
Submitted by
admin
on January 17, 2018 - 9:44pm
Source:
GoinPharma
News Tags:
Merck
Keytruda
non-squamous cell non-small cell lung cancer
Headline:
Merck & Co.’s shares rise over 7% thanks to new positive clinical results from Keytruda
Do Not Allow Advertisers to Use My Personal information
